stockmarketnews.online EDGAR snapshot
The Filings Docket Corporate filings, explained: what large U.S. companies filed with the SEC, and what it means.

In re: PFIZER INC · CIK 0000078003

When will Pfizer Inc. file its next 10-Q?

PFE · NYSE
Snapshot

Pfizer Inc. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 27, 2026, between Nov. 2, 2026 and Nov. 4, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 6, 2026.

How the next-report window is calculated

Pfizer Inc.'s most recent periodic report on file is a Form 10-Q for the period ended June 28, 2026, filed Aug. 4, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 27, 2026, and that report is a Form 10-Q.

SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 6, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Pfizer Inc. filed between 36 and 38 days after period end (median 37 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.

Pfizer Inc.: days from period end to 10-Q/10-K filing 10-Q for period ended 2024-09-29: filed 36 days later; 10-K for period ended 2024-12-31: filed 58 days later; 10-Q for period ended 2025-03-30: filed 36 days later; 10-Q for period ended 2025-06-29: filed 37 days later; 10-Q for period ended 2025-09-28: filed 37 days later; 10-K for period ended 2025-12-31: filed 57 days later; 10-Q for period ended 2026-03-29: filed 37 days later; 10-Q for period ended 2026-06-28: filed 37 days later. 10-Q due: 40d 10-K due: 60d 10-Q · Sept. 29 24 36d 10-K · Dec. 31 24 58d 10-Q · March 30 25 36d 10-Q · June 29 25 37d 10-Q · Sept. 28 25 37d 10-K · Dec. 31 25 57d 10-Q · March 29 26 37d 10-Q · June 28 26 37d days from period end to filing date →

Recent filings by Pfizer Inc.

Most recent 25 filings excluding insider Forms 3/4/5/144 · SEC EDGAR, retrieved Oct. 16, 2026
FiledFormWhat it isDocument
N-PX Annual report of proxy votes cast Open N-PX filed 2026-08-31 · Index 0000078003-26-000111
10-Q Quarterly report with unaudited financial statements for the period ended June 28, 2026 Open 10-Q filed 2026-08-04 · Index 0000078003-26-000095
8-K Released earnings or financial results Open 8-K filed 2026-08-04 · Index 0000078003-26-000094
8-K Information shared under Regulation FD Open 8-K filed 2026-06-18 · Index 0000078003-26-000087
8-K Executive or board change, or executive pay arrangement Open 8-K filed 2026-06-18 · Index 0000078003-26-000085
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-16 · Index 0000078003-26-000080
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-16 · Index 0000078003-26-000078
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-05-12 · Index 0000078003-26-000067
S-8 Registration of shares for employee benefit plans Open S-8 filed 2026-05-05 · Index 0000078003-26-000058
10-Q Quarterly report with unaudited financial statements for the period ended March 29, 2026 Open 10-Q filed 2026-05-05 · Index 0000078003-26-000054
8-K Released earnings or financial results Open 8-K filed 2026-05-05 · Index 0000078003-26-000053
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-05-01 · Index 0002100119-26-001294
8-K Reported shareholder vote results Open 8-K filed 2026-04-27 · Index 0000078003-26-000044
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-03-27 · Index 0000102909-26-002101
ARS Annual report delivered to shareholders Open ARS filed 2026-03-12 · Index 0000078003-26-000038
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-03-12 · Index 0000078003-26-000035
DEF 14A Definitive proxy statement for a shareholder meeting Open DEF 14A filed 2026-03-12 · Index 0000078003-26-000033
10-K Annual report with audited financial statements for the period ended Dec. 31, 2025 Open 10-K filed 2026-02-26 · Index 0000078003-26-000026
13D/A Amendment to an active-ownership (13D) report Open SCHEDULE 13D/A filed 2026-02-13 · Index 0000078003-26-000022
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-02-13 · Index 0000078003-26-000020
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-02-13 · Index 0000078003-26-000018
8-K Released earnings or financial results Open 8-K filed 2026-02-03 · Index 0000078003-26-000005
8-K Information shared under Regulation FD Open 8-K filed 2025-12-16 · Index 0000078003-25-000167
8-K Other events the company chose to report Open 8-K filed 2025-11-21 · Index 0001193125-25-291406
8-K Other events the company chose to report Open 8-K filed 2025-11-13 · Index 0000078003-25-000159

What Pfizer Inc.'s 8-Ks were about in the past year

Pfizer Inc. filed 10 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.

ItemMeaningTimes
9.01Financial Statements and Exhibits7
2.02Results of Operations and Financial Condition4
7.01Regulation FD Disclosure2
8.01Other Events2
5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers1
5.07Submission of Matters to a Vote of Security Holders1

See what each 8-K item means.